Agenda

Mediktor is the most accurate AI based medical chatbot for triage and prediagnosis.

President of Barcelona Health Hub

BHH is a nonprofit private association created to promote innovation in digital health and its transfer to the sector, linking startups, health organizations, companies and investors.

Member of the Board at Antai Venture Builder & Member of Antai Business Angels.

Angel investor in more than 20 Startups.

2015-2016 General Manager at Eurekaparts.com

The largest Spanish online company with a full range of garden equipment and spare parts and accessories.

20 years of experience in management.

From 1998 to 2015 holding different management positions in Europastry, the leading frozen Bread&Pastry manufacturer in Spain and Portugal. Helping the company to rise from 30 to more than 400 Millions € of turnover.

From 1996, Member of the Board in Greens Power Products, the exclusive Honda Power Products distributor for Spain. Greens has led the Agricultural, Garden and Marine power products sector since 1978.

Ms. Marta Villanueva Cendán, born in 1986 in Barcelona, is councillor for Health, People with Disabilities and Strategy Against Loneliness at Barcelona City Council. She is also councillor of the District of Sant Andreu.

With a degree in political science from the UB and several post-graduate degrees, she has held positions in the PSC, always in organizational or health profiles. Ms Villanueva also has a degree in nursing from the UB. Until her appointment as a councillor, she was working as a nurse at the Hospital Clínic de Barcelona.

Inma Rodríguez is Market Intelligence Manager at ACCIÓ. Belonging to the Ministry of Business and Labour of the Government of Catalonia, ACCIÓ is the agency for business competitiveness.

Graduated in Economics (1997) and in Business Administration and Management (1998) from the Autonomous University of Barcelona (UAB), he also completed a specialized post-graduate course in human resource management and industrial relations at Pompeu Fabra University (2000-2001) and training courses in entrepreneurship and mentoring at ESADE, IESE and the Massachusetts Institute of Technology (MIT).

Barry brings with him seven years’ experience as a Biomedical Engineer and Sr. Scientific Reviewer at FDA/CDRH/ODE and FDA’s Boston District. This government experience was followed with over 17 years in midlevel and executive management positions in small start-up/large multinational medical device companies.  Market responsibilities included United States, EU, South America, Canada, Japan and South Korea. Barry has extensive experience with product development and FDA negotiations of US regulatory strategy (EUA, DeNovo 510(k) with clinical data, Breakthrough Designation, etc.). In the area of diagnostics this experience includes diagnostic devices for COVID-19, diagnostics using biomarkers in sweat, diagnostics using breath (diabetes and lung cancer), measurement of radiation exposure, and diagnosis of stroke.  He has written multiple 510(k)s, IDEs, and PMAs in cardiovascular,  orthopedic/sports medicine, spine, general surgery, gastroenterology, neurology/neurosurgery, and Ob/Gyn. Technologies embedded in these products included Machine Learning/AI, 3D Printing, and Software.

Daniele Lezzi has a Ph.D on Computer Engineer from University of Lecce. Since 2008, he has been a researcher at the Barcelona Supercomputing Center (BSC), a world-renowned research center specializing in high-performance computing and data analysis, home to MareNostrum5, one of the world's most powerful supercomputers, within a European supercomputing collaboration that includes, among others, LEONARDO at CINECA.

Natalia Cullell is post-doctoral fellow who graduated in Human Biology in 2014 from Pompeu Fabra University (Barcelona, Spain), achieving an average grade of 9.13 and receiving 22 distinctions. Subsequently, she was granted a scholarship to pursue a Master's in Pharmaceutical and Biotechnological Industry at the same University. Natalia obtained her Doctorate in Medicine and Translational Research in June 2023 with Excellent grade and Cum laudem distinction.
Since 2015, she has been working as a genetist researcher and lab manager at Fundació Docència i Recerca Mútua Terrassa, contributing to the Mutua Neuroscience group led by Dr. Jerzy Krupinski as the principal investigator. Additionally, she collaborates with the Neurovascular Pharmacogenetics and Genomics group at the Sant Pau Research Institute, under the leadership of Dr. Israel Fernández Cadenas and in the Life Science Department from the Metropolitan Manchester University, under the supervision of Prof. Carol Ainley, holding an agreement with these Institutions. Her primary area of study centers around the use of omic technologies in complex diseases. It includes genetics, epigenetics, and pharmacogenetics of neurovascular diseases. She has collaborated on up to 15 distinct funded projects funded, leading as principal investigator four of them, including the recently awarded project by the Barcelona Council "Clima Project" in the call for young and emerging research projects. Throughout this period, she has participated in courses and conferences within the genetics, epigenetics and neurovascular diseases field. She has presented at international conferences with 10 oral presentations. Recently, she has received the Young Investigator Award for her presentation in the European Stroke Organisation Conference (ESOC) 2024. Additionally, Natalia has instructed the "Genetics and Neurology" class in the Clinical Neurology Training Course organized by the Catalan Society of Neurology for neurology residents. She has also been an instructor in a course organized by the Spanish Consortium for the Study of Cerebral Infarction Genetics (GENESTROKE) and has conducted pharmacogenetics classes for pharmacy students at Ramón Llull University.
Natalia has contributed to more than 55 scientific publications (Google scholar: https://acortar.link/4XMNcq), eight of which she authored as the first author. Furthermore, she authored a book chapter on generating genetic scores in the "Stroke Biomarkers" book. Her H-index is 21 (Scopus). Natalia Cullell actively participates in the International Stroke Genetics Consortium (ISGC), the Spanish Stroke Genetics Consortium (GENESTROKE), and the Carlos III Health Institute's RETICS network (Ricors-Ictus).

Consultant Medical Oncologist specializing in the Digestive Tumors and Melanoma Unit at ICO-Badalona until 2017. Since 2017, Consultant Medical Oncologist in the Thoracic Tumors Unit at Parc Taulí University Hospital. Currently serving as a specialist in this unit. Coordinator of the Thoracic Tumors Unit. Chair of the Thoracic Tumor Board and the Functional Thoracic Oncology Unit (UFOT). Supervisor of Medical Oncology residents. Member of the Cancer Research Group at the Parc Taulí Institute for Research and Innovation (I3PT-CERCA) since 2016. Teaching Collaborator at the Autonomous University of Barcelona (UAB), Parc Taulí Teaching Unit.

Neuróloga especializada en enfermedades inflamatorias del sistema nervioso central y Coordinadora de la Unidad de Neurología Autoinmune en el Hospital de la Santa Creu i Sant Pau. Su investigación se ha centrado en la esclerosis múltiple (EM), el estudio de la vía visual como modelo de neurodegeneración y la identificación de biomarcadores con valor diagnóstico y pronóstico. Tras desarrollar su trayectoria en un centro de referencia internacional (Cemcat, Hospital Vall d’Hebron), actualmente lidera un grupo de investigación emergente en el Institut de Recerca del Hospital de la Santa Creu i Sant Pau, con el objetivo de consolidar una línea de investigación estable en neurología autoinmune y biomarcadores en patologías del SNC. Su experiencia en el liderazgo de proyectos competitivos, su participación en redes internacionales y su contribución al desarrollo de los nuevos criterios diagnósticos de la EM refuerzan su trayectoria en este campo. En ese sentido, ha sido investigadora principal de dos proyectos financiados por el Instituto de Salud Carlos III: PI22/01589 y PI17/02162, que han permitido estudiar la vía visual desde las fases iniciales de la EM y han generado resultados clave en el ámbito del diagnóstico precoz y los resultados han sido incorporados en la nueva revisión de los criterios diagnósticos.

Passionate about pharmaceutical marketing and sales, understanding it as a vehicle to improve people's health. Proven success in the positioning and repositioning of products with significant sales growth. Strong strategic vision. Quick decision-making in complex situations. Skilled at identifying new business opportunities. Ability to turn around challenging client situations. Expert in Marketing and Sales in the pharmaceutical market, both nationally and internationally.

Marja Huiskamp is General Manager of Madrid Health Hub, a non-profit organization advancing innovation in digital health. With over 15 years of experience in strategic program management and stakeholder engagement, she builds ecosystems, fosters partnerships, and positions Madrid as an epicenter of digital health. Previously, she served as Chief Communication Officer at Barcelona Health Hub, where she successfully established the organization as a global household name in digital health. Before that, she led human rights initiatives at the Embassy of the Netherlands in Chile. As a dynamic public speaker, Marja is passionate about impactful communication, connecting with audiences, and making a lasting difference where it matters most.

Michael Blackman was born in Georgetown, British Guiana (now Guyana) in 1958. He is best known as the Managing Director of Integrated Systems Europe (ISE), the world's largest exhibition dedicated to audiovisual and technology integration.

Especialista en Medicina Física y Rehabilitación en el Hospital Clínic de Barcelona y colaboradora docente en los Grados de Medicina e Ingeniería Biomédica de la Universidad de Barcelona. Asimismo, participo en proyectos de investigación en el área de la prehabilitación.
Cuento con experiencia en la prescripción de ejercicio físico adaptado para pacientes con enfermedades cardiopulmonares y oncológicas, así como en el abordaje del suelo pélvico. Actualmente, mi actividad se centra en la evaluación y tratamiento de la sarcopenia y la fragilidad.Tengo especial interés en la incorporación de nuevas tecnologías en la práctica clínica y favorecer la innovación en rehabilitación.

Más de cinco años de experiencia en gestión de proyectos de transformación digital, liderando iniciativas estratégicas en Sanitas Seguros. He coordinado el lanzamiento de productos y servicios digitales a nivel nacional e internacional. Mi trabajo diario combina visión estratégica, innovación y ejecución, con experiencia en internacionalización y adaptación de servicios a nuevos mercados. Anteriormente, en Sanitas Dental, trabajé en mejorar la experiencia del cliente. Soy graduada en ADE con especialización en comercio internacional y poseo un máster en Asuntos Internacionales por ICADE y Georgetown University.

Carlos is a graduate in Leadership, Entrepreneurship and Innovation from the University of Mondragon. He has six years of professional experience in the management of digital business projects, through his career he founded of a digitalization and innovation consultancy named MAKNAD (2017 - 2020) that operated internationally working in San Francisco and Paris. Thanks to his education and professional experience, Carlos has diverse knowledge and skills in project management, growth strategies, funding, business strategy and digital marketing.

In december 2020 he founded TRAK, an AI powered digital physiotherapy medical software.

I work as an Innovation Consultant at Catalonia Trade & Investment, where I focus on strengthening connections between the Catalan and UK ecosystems. My role involves helping Catalan companies—particularly in digital health and MedTech—understand and navigate the UK healthcare system, including the NHS. I support companies in identifying opportunities, building partnerships, and expanding internationally. At Catalonia Trade & Investment, we aim to drive innovation, promote global growth, and facilitate strategic cross-border collaborations.

Mathilde has twenty years of experience in innovation, technology intelligence, and R&D. She currently manages the Future of Health Grant, an initiative to foster innovation in digital health and accelerate the development of startups in that space. Previously, Mathilde worked for Cisco, where she led different innovation initiatives, ranging from open-innovation projects to startup challenges to employee innovation programs. The programs under her supervision have supported thousands of intrapreneurs and entrepreneurs and received multiple industry awards.

Oliver is the Senior Open Innovation Officer at Barcelona Health Hub, where he leverages extensive experience in healthcare, innovation, and digital transformation to position BHH as a leader in the healthcare innovation ecosystem. He has worked across various sectors, including FMCG and Pharma, with experience in Spain, the U.S. (Boston), and the U.K. (London). Oliver holds a master’s degree in digital transformation and has spent several years as a market research and innovation consultant.